Ace Therapeutics Expands Access to Cutting-Edge CKD Contract Research Services with Validated Animal Models for Renal Drug Development
New York, United States, January 26, 2026 — Ace Therapeutics recently underscored its commitment to advancing chronic kidney disease (CKD) therapeutic development by offering one-stop CKD contract research services with a robust portfolio of validated… Read More »Ace Therapeutics Expands Access to Cutting-Edge CKD Contract Research Services with Validated Animal Models for Renal Drug Development





